Before revision:  We thus discovered a sizable MCI subpopulation with homogeneous brain abnormalities and highly predictable clinical trajectories, which may represent an excellent recruitment target for clinical trials at the prodromal stage of Alzheimer's disease.
After revision:  We thus discovered a sizable MCI subpopulation which represents an excellent recruitment target for clinical trials at the prodromal stage of Alzheimer's disease.